Gossamer Bio (GOSS) Leases: 2022-2025
Historic Leases for Gossamer Bio (GOSS) over the last 4 years, with Sep 2025 value amounting to $4.4 million.
- Gossamer Bio's Leases fell 27.75% to $4.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $4.4 million, marking a year-over-year decrease of 27.75%. This contributed to the annual value of $5.1 million for FY2024, which is 63.24% up from last year.
- As of Q3 2025, Gossamer Bio's Leases stood at $4.4 million, which was down 4.68% from $4.6 million recorded in Q2 2025.
- Gossamer Bio's Leases' 5-year high stood at $7.9 million during Q1 2022, with a 5-year trough of $1.7 million in Q2 2024.
- Over the past 3 years, Gossamer Bio's median Leases value was $4.5 million (recorded in 2023), while the average stood at $4.2 million.
- Its Leases has fluctuated over the past 5 years, first tumbled by 63.44% in 2024, then skyrocketed by 174.85% in 2025.
- Quarterly analysis of 4 years shows Gossamer Bio's Leases stood at $5.9 million in 2022, then slumped by 47.01% to $3.1 million in 2023, then skyrocketed by 63.24% to $5.1 million in 2024, then declined by 27.75% to $4.4 million in 2025.
- Its last three reported values are $4.4 million in Q3 2025, $4.6 million for Q2 2025, and $4.8 million during Q1 2025.